Sodium–Glucose Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes

Diabetes Care- United States

doi 10.2337/dc19-0849

Full Text

Abstract

Available in

Categories

Internal Medicine

Specialized Nursing

Date

July 11, 2019

Authors

Antonios Douros

Laurent Azoulay

Publisher

American Diabetes Association

Related search

Use of Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections in Type 2 Diabetes Patients: A Systematic Review

Revista da Associacao Medica Brasileira

English

Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Urinary Excretion of Intact and Total Angiotensinogen in Patients With Type 2 Diabetes

Journal of Investigative Medicine

Molecular Biology

English

Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Hepatic Fibrosis in Patients With Type 2 Diabetes: A Chart-Based Analysis

Journal of Endocrinology and Metabolism

English

Effects of Sodium Glucose Cotransporter Type 2 Inhibitors on Heart Failure

Diabetes, Obesity and Metabolism

Internal Medicine

English

Heart Failure Prevention With Sodium‐glucose Cotransporter 2 Inhibitors

Journal of Diabetes

English

Renal Glucose Handling: Impact of Chronic Kidney Disease and Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 2 Diabetes

Internal Medicine

Specialized Nursing

English

Cardiovascular Effects of Sodium Glucose Cotransporter 2 Inhibitors

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

Internal Medicine

English

Hemodynamic Effects of Sodium-Glucose Cotransporter 2 Inhibitors

Journal of Clinical Medicine Research

English

Sodium-Glucose Cotransporter 2 Inhibitors Reduce Prandial Insulin Doses in Type 2 Diabetic Patients Treated With the Intensive Insulin Therapy

Journal of Clinical Medicine Research

English